Department of Cardiology, Faculty of Medicine, Istanbul Yeni Yuzyil University, Gaziosmanpasa Hospital, Gaziosmanpasa, Istanbul, Turkey. Email:
Department of Family Medicine, Faculty of Medicine, Istanbul Yeni Yuzyil University, Gaziosmanpasa Hospital, Gaziosmanpasa, Istanbul, Turkey.
Cardiovasc J Afr. 2020 Nov-Dec;31(6):335-338. doi: 10.5830/CVJA-2020-016. Epub 2020 May 5.
Coronavirus disease 2019 (COVID-19) is a recently recognised pandemic spreading rapidly from Wuhan, Hubei, to other provinces in China and to many countries around the world. The number of COVID-19-related deaths is steadily increasing. Acute ST-segment elevation myocardial infarction (STEMI) is a disease with high morbidity and mortality rates, and primary percutaneous coronary intervention is usually recommended for the treatment. A patient with diabetes mellitus and hypertension for five years was admitted to the emergency unit with symptoms of fever, cough and dyspnoea. These symptoms were consistent with viral pneumonia and a COVID PCR test was performed, which tested positive three days later. The patient had chest pain on the eighth day of hospitalisation. On electrocardiography, simultaneous acute inferior and anterior STEMI were identified. High levels of stress and increased metabolic demand in these patients may lead to concomitant thrombosis of different coronary arteries, presenting with two different STEMIs.
2019 年冠状病毒病（COVID-19）是一种最近被认识的传染病，从中国湖北武汉迅速传播到中国其他省份和世界许多国家。与 COVID-19 相关的死亡人数正在稳步增加。急性 ST 段抬高型心肌梗死（STEMI）是一种发病率和死亡率都很高的疾病，通常推荐进行经皮冠状动脉介入治疗。一名患有糖尿病和高血压五年的患者因发热、咳嗽和呼吸困难症状被收入急诊部。这些症状与病毒性肺炎一致，三天后进行了 COVID PCR 检测，结果呈阳性。患者在住院第八天出现胸痛。心电图显示同时发生急性下壁和前壁 STEMI。这些患者的压力水平升高和代谢需求增加可能导致不同冠状动脉同时发生血栓形成，表现为两种不同的 STEMI。
